GAMMA Investing »

Inhibrx Biosciences shares owned by GAMMA Investing

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.3k 145 15.66
2024-06-30 $28 2 14.00

More positions owned by GAMMA Investing

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Amazon Common Stock (AMZN)
Meta Platforms Inc Cl A Common Stock (META)
Jpmorgan Chase Common Stock (JPM)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Eli Lilly Common Stock (LLY)
Ishares Inc Core Msci Emkt Etf (IEMG)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Tr National Mun Etf Etf (MUB)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Visa Inc Com Cl A Common Stock (V)
Home Depot Common Stock (HD)

View all positions for GAMMA Investing

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Slotnik Capital
Geode Capital Management
Morgan Stanley
Caption Management
Kennedy Capital Management
Arrowpoint Asset Management
Susquehanna International
State Street Corporation
Schonfeld Strategic Advisors

View all funds holding Inhibrx Biosciences